U.S. Markets closed

Insider Buying: The Biotron Limited (ASX:BIT) Independent & Non-Executive Director Just Bought AU$50k Worth Of Shares

Simply Wall St

Whilst it may not be a huge deal, we thought it was good to see that the Biotron Limited (ASX:BIT) Independent & Non-Executive Director, Robert Thomas, recently bought AU$50k worth of stock, for AU$0.05 per share. That purchase might not be huge but it did increase their holding by 38%.

See our latest analysis for Biotron

The Last 12 Months Of Insider Transactions At Biotron

In fact, the recent purchase by Robert Thomas was the biggest purchase of Biotron shares made by an insider individual in the last twelve months, according to our records. Even though the purchase was made at a significantly lower price than the recent price (AU$0.069), we still think insider buying is a positive. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

You can see a visual depiction of insider transactions (by individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

ASX:BIT Recent Insider Trading, January 23rd 2020

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Insider Ownership

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. From our data, it seems that Biotron insiders own 9.9% of the company, worth about AU$5.9m. But they may have an indirect interest through a corporate structure that we haven't picked up on. Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!

So What Does This Data Suggest About Biotron Insiders?

The recent insider purchase is heartening. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making losses. On this analysis the only slight negative we see is the fairly low (overall) insider ownership; their transactions suggest that they are quite positive on Biotron stock. Along with insider transactions, I recommend checking if Biotron is growing revenue. This free chart of historic revenue and earnings should make that easy.

Of course Biotron may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.